In a follow-up study, the same group reported that the CCK analogue ameliorated cognitive deficits and regulated mitochondrial dynamics by activating the CCKB receptor and the AMPK/Drp1 pathway in APP/PS1 mice (Hao et al., 2024). The gene discussed is APP; the disease is Cognitive impairment.